Genprex Stock (NASDAQ: GNPX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 422.00 / 416.59K |
Day Range | - - - |
52 Wk Range | 0.28 - 18.59 |
Market Cap | $970.70K |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 20 |
Short Interest | 1.59% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Genprex (NASDAQ:GNPX) through any online brokerage.
Other companies in Genprex’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
Genprex has a consensus price target of $6.50.
The stock price for Genprex (NASDAQ: GNPX) is $0.375 last updated September 23, 2024 at 5:21 AM EDT.
There are no upcoming dividends for Genprex.
Genprex’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Genprex.
Genprex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.